SAN FRANCISCO, December 9, 2020 — R-Zero, a biosafety company dedicated to developing the most effective hospital-grade UV-C disinfection technologies to reduce the spread of infectious disease, today announced its official membership with the International Ultraviolet Association, Inc. (IUVA). IUVA is a leading educational and advocacy organization composed of UV equipment vendors, scientists, engineers, consultants, and members of the medical profession.
Notably, the IUVA has recently been accepted into the U.S. Food and Drug Administration’s (FDA) “Network of Experts” program, where IUVA members will serve as an independent source for the FDA to query, when scientific facts and objective analyses regarding UV are needed. As a member of the FDA’s Network of Experts program, the IUVA will collaborate directly with the FDA, lending the expertise of its members. A proponent of driving education and innovation of UV technology forward, R-Zero is qualified to deliver unique expertise when it comes to the application of UV-C disinfection in different sectors across the economy.
R-Zero’s flagship product, Arc, is the first hospital-grade germicidal UV disinfection device that is both financially and operationally accessible to the mass market. Efficacy testing from CDC and EPA recognized independent lab tests shows that Arc can destroy over 99.99% of the most common and harmful pathogens in just 7 minutes. As a member of IUVA, R-Zero aims to advance the standards and regulations that enable broad distribution and application of hospital-grade UV products, like Arc. As part of R-Zero’s affiliation with IUVA, CEO and co-founder, Grant Morgan, has also joined the organization’s Coronavirus Response Task Force.
“We are honored to have the opportunity to work alongside the best scientists, engineers, and UV technology experts in the world to advance IUVA’s mission,” said Grant Morgan, CEO and co-founder of R-Zero. “As a member and supporter of IUVA, we aim to continue driving progress to increase both awareness and access to UV technology with the ultimate goal of enhancing the quality of human life. We believe UV-C is a critical tool to fight not only the novel coronavirus today, but all pathogens that threaten human health.”
R-Zero was founded in the early stages of the pandemic by co-founders Ben Boyer, Grant Morgan and Eli Harris after recognizing a unique opportunity to revolutionize the $20B+ infection prevention industry and help businesses reopen and increase employee/customer safety. UV-C technology has long been used as a disinfectant, but until now, access had been limited to hospitals, which pay up to $125,000 per unit. Alternatively, R-Zero’s Arc successfully offers hospital-grade safety and efficacy at a fraction of the price. Additionally, BLE, LTE-M and GPS connectivity provides organizations with a first-of-its-kind auditable trail of disinfection activities, making a previously invisible process visible for the first time — a step forward in the safe reopening of common spaces.
“As an organization, the IUVA’s mission is to advance the science, engineering and applications of ultraviolet technologies, in order to enhance the quality of human life, said Dr. Ron Hofmann, Professor at the University of Toronto, and President of the IUVA. “Our members represent UV experts from around the world, and continue to play a vital role in the efforts to provide advocacy on the use of UV technology to the education, industry, research and public policy sectors worldwide.”
View official press release here.
About R-Zero: R-Zero is the first biosafety company dedicated to making the spaces we all live, learn, work, and play safer and clinically clean. Founded to help organizations protect what matters most, R-Zero’s suite of thoughtfully designed, hospital-grade technologies and science-backed protocols reduces the transmission of pathogens and the diseases they cause – from the coronavirus to the common cold. R-Zero’s flagship product, Arc, is a touchless, hospital-grade UV-C disinfection device, designed to be operationally and financially accessible to organizations of all shapes and sizes. BLE, LTE-M and GPS connectivity shares usage data in real-time, providing organizations with an auditable trail of all disinfection activities for the first time. Results from recent (CDC and EPA recognized) independent lab tests prove Arc’s hospital-grade efficacy, successfully destroying over 99.99% of pathogens (including human coronavirus and norovirus) in a 1,000 sq ft space, in just 7 minutes. For more information, visit www.rzero.com.
About IUVA: The International Ultraviolet Association, Inc. is a leading educational and advocacy organization composed of UV equipment vendors, scientists, engineers, consultants, and members of the medical profession. IUVA is committed to advancing the sciences, engineering & applications of ultraviolet technologies to enhance the quality of human life & to protect the environment. In addition to their research and advocacy work, IUVA publishes a regular Newsletter (IUVA News) to keep members informed of new developments in the applications of ultraviolet technology and organizes periodic international and national conferences focused on ultraviolet technologies. https://www.iuva.org
More posts you might like
Discover UV-C disinfection safety essentials and what safeguards your UV-C disinfection system should include.
What it means to be a Double Bottom Line Company, and why that matters to us. We are thrilled to announce that R-Zero has closed $15M in Series A funding led by DBL Partners (Ira Ehrenpreis), with participation from a number of other world-class investors including Bedrock Capital (Geoff Lewis) and HAX / SOSV (Duncan […]
Navigating the crowded UV-C market can appear daunting, but it doesn’t have to be. Here are four key considerations to ensure you’re selecting the best UV-C device for your environment.